Analysis Imugene Limited (IUGNF)
5/27/2024
Analysis of Imugene Limited (IUGNF)
Imugene Limited (IUGNF) has been showing some volatility in its stock price over the past few days. The RSI indicator has been fluctuating around the 40-50 range, indicating a neutral to slightly bearish sentiment in the market.The MACD indicator has been hovering around the zero line, suggesting a lack of strong momentum in either direction. The moving averages (SMA, EMA, WMA) have been relatively close to each other, indicating a lack of clear trend direction.
Overall, based on the technical indicators, it seems that Imugene Limited is currently in a consolidation phase with no clear trend. Traders and investors may want to wait for a clearer signal before making any significant trading decisions.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It is important to note that these are analyst estimates and actual performance may vary.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecast, indicating that some analysts may expect the price to increase in the future.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating good financial performance. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 31, 2024. The company shows a good return on assets and return on equity.
In terms of stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock has a high market capitalization and enterprise value.
Valuation metrics show a high PEG ratio, forward and trailing P/E ratios, and price to book and price to sales ratios. The company's stock price summary includes beta, moving averages, and the 52-week low and high prices.
Lastly, the dividends and splits information shows details about dividend rates, payout ratios, dividend dates, and historical splits for the company.
Income statement 💸
Here are the revenue figures for the past four fiscal years:- Fiscal Year 2020: $274,515,000,000
- Fiscal Year 2021: $365,817,000,000
- Fiscal Year 2022: $394,328,000,000
- Fiscal Year 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. There was a significant increase in revenue from FY 2020 to FY 2021, indicating strong growth.
2. The revenue continued to grow from FY 2021 to FY 2022, reaching the highest point in that year.
3. There was a slight decrease in revenue from FY 2022 to FY 2023, suggesting a possible stabilization or slight decline in sales.
Overall, the company has shown a positive revenue trend over the past four years, with substantial growth followed by a period of relative stability.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. The company has been investing in leases, land, and improvements over the years.
9. Retained earnings have fluctuated but have generally been positive.
10. The company has been maintaining a balance between current and non-current assets and liabilities.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant changes each year, with large amounts being spent on common stock repurchase and debt issuance/payments.
6. Investing activities also vary, with notable amounts spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share both quarterly and annually, with an increase projected for the upcoming periods compared to the previous year. It indicates potential growth and improvement in the company's financial performance according to analysts' forecasts.
MACD of IUGNF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
